Multiple Assemblies exist for SMTL entry 4y95
Crystal structure of the kinase domain of Bruton's tyrosine kinase with mutations in the activation loop; X-RAY DIFFRACTION 1.60 Å

	SMTL ID 4y95.1 Ligands 4-tert-butyl-N-[2-methyl-3-(4-methyl-6-{[4-(morpholin-4-ylcarbonyl)phenyl]amino}-5-oxo-4,5-dihydropyrazin-2-yl)phenyl]benzamide; GLYCEROL; BETA-MERCAPTOETHANOL Polypeptides Non-specific protein-tyrosine kinase Oligo-state monomer
	SMTL ID 4y95.2 Ligands 4-tert-butyl-N-[2-methyl-3-(4-methyl-6-{[4-(morpholin-4-ylcarbonyl)phenyl]amino}-5-oxo-4,5-dihydropyrazin-2-yl)phenyl]benzamide; GLYCEROL; BETA-MERCAPTOETHANOL; 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL Polypeptides Non-specific protein-tyrosine kinase Oligo-state monomer
	SMTL ID 4y95.3 Ligands 4-tert-butyl-N-[2-methyl-3-(4-methyl-6-{[4-(morpholin-4-ylcarbonyl)phenyl]amino}-5-oxo-4,5-dihydropyrazin-2-yl)phenyl]benzamide; GLYCEROL; BETA-MERCAPTOETHANOL; 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL Polypeptides Non-specific protein-tyrosine kinase Oligo-state monomer
	SMTL ID 4y95.4 Ligands 4-tert-butyl-N-[2-methyl-3-(4-methyl-6-{[4-(morpholin-4-ylcarbonyl)phenyl]amino}-5-oxo-4,5-dihydropyrazin-2-yl)phenyl]benzamide; GLYCEROL Polypeptides Non-specific protein-tyrosine kinase Oligo-state monomer